Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents | MicrobiomeTrials← Back to trialsNCT02264678
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2014-10-31Est. Completion: 2025-03-04
Enrollment target: 358 participants Locations- Research Site, Duarte, California, United States
- Research Site, Irvine, California, United States
- Research Site, Los Angeles, California, United States
- Research Site, Los Angeles, California, United States
- Research Site, Newport Beach, California, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, New York, New York, United States
- Research Site, Philadelphia, Pennsylvania, United States
- Research Site, Bordeaux, France
- Research Site, Lyon, France
- Research Site, Saint-Herblain, France
- Research Site, Villejuif, France
- Research Site, Goyang-si, South Korea
- Research Site, Seongnam-si, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Seoul, South Korea
- Research Site, Bristol, United Kingdom
- Research Site, Cambridge, United Kingdom
- Research Site, Coventry, United Kingdom
Research Site, London, United KingdomResearch Site, London, United KingdomResearch Site, London, United KingdomResearch Site, London, United KingdomResearch Site, Manchester, United KingdomResearch Site, Oxford, United KingdomResearch Site, Sutton, United KingdomResearch Site, Withington, United Kingdom